Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens.
Protection against virulent pathogens that cause acute, fatal disease is often hampered by development of microbial resistance to traditional chemotherapeutics. Further, most successful pathogens possess an array of immune evasion strategies to avoid detection and elimination by the host. Developmen...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-05-01
|
| Series: | PLoS Pathogens |
| Online Access: | http://europepmc.org/articles/PMC2877747?pdf=render |
| _version_ | 1819060079677145088 |
|---|---|
| author | Robin Ireland Norma Olivares-Zavaleta Jonathan M Warawa Frank C Gherardini Clayton Jarrett B Joseph Hinnebusch John T Belisle Jeffery Fairman Catharine M Bosio |
| author_facet | Robin Ireland Norma Olivares-Zavaleta Jonathan M Warawa Frank C Gherardini Clayton Jarrett B Joseph Hinnebusch John T Belisle Jeffery Fairman Catharine M Bosio |
| author_sort | Robin Ireland |
| collection | DOAJ |
| description | Protection against virulent pathogens that cause acute, fatal disease is often hampered by development of microbial resistance to traditional chemotherapeutics. Further, most successful pathogens possess an array of immune evasion strategies to avoid detection and elimination by the host. Development of novel, immunomodulatory prophylaxes that target the host immune system, rather than the invading microbe, could serve as effective alternatives to traditional chemotherapies. Here we describe the development and mechanism of a novel pan-anti-bacterial prophylaxis. Using cationic liposome non-coding DNA complexes (CLDC) mixed with crude F. tularensis membrane protein fractions (MPF), we demonstrate control of virulent F. tularensis infection in vitro and in vivo. CLDC+MPF inhibited bacterial replication in primary human and murine macrophages in vitro. Control of infection in macrophages was mediated by both reactive nitrogen species (RNS) and reactive oxygen species (ROS) in mouse cells, and ROS in human cells. Importantly, mice treated with CLDC+MPF 3 days prior to challenge survived lethal intranasal infection with virulent F. tularensis. Similarly to in vitro observations, in vivo protection was dependent on the presence of RNS and ROS. Lastly, CLDC+MPF was also effective at controlling infections with Yersinia pestis, Burkholderia pseudomallei and Brucella abortus. Thus, CLDC+MPF represents a novel prophylaxis to protect against multiple, highly virulent pathogens. |
| first_indexed | 2024-12-21T14:21:17Z |
| format | Article |
| id | doaj.art-93aea17ff17e45c59cca2be8c7ad4968 |
| institution | Directory Open Access Journal |
| issn | 1553-7366 1553-7374 |
| language | English |
| last_indexed | 2024-12-21T14:21:17Z |
| publishDate | 2010-05-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj.art-93aea17ff17e45c59cca2be8c7ad49682022-12-21T19:00:46ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742010-05-0165e100092110.1371/journal.ppat.1000921Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens.Robin IrelandNorma Olivares-ZavaletaJonathan M WarawaFrank C GherardiniClayton JarrettB Joseph HinnebuschJohn T BelisleJeffery FairmanCatharine M BosioProtection against virulent pathogens that cause acute, fatal disease is often hampered by development of microbial resistance to traditional chemotherapeutics. Further, most successful pathogens possess an array of immune evasion strategies to avoid detection and elimination by the host. Development of novel, immunomodulatory prophylaxes that target the host immune system, rather than the invading microbe, could serve as effective alternatives to traditional chemotherapies. Here we describe the development and mechanism of a novel pan-anti-bacterial prophylaxis. Using cationic liposome non-coding DNA complexes (CLDC) mixed with crude F. tularensis membrane protein fractions (MPF), we demonstrate control of virulent F. tularensis infection in vitro and in vivo. CLDC+MPF inhibited bacterial replication in primary human and murine macrophages in vitro. Control of infection in macrophages was mediated by both reactive nitrogen species (RNS) and reactive oxygen species (ROS) in mouse cells, and ROS in human cells. Importantly, mice treated with CLDC+MPF 3 days prior to challenge survived lethal intranasal infection with virulent F. tularensis. Similarly to in vitro observations, in vivo protection was dependent on the presence of RNS and ROS. Lastly, CLDC+MPF was also effective at controlling infections with Yersinia pestis, Burkholderia pseudomallei and Brucella abortus. Thus, CLDC+MPF represents a novel prophylaxis to protect against multiple, highly virulent pathogens.http://europepmc.org/articles/PMC2877747?pdf=render |
| spellingShingle | Robin Ireland Norma Olivares-Zavaleta Jonathan M Warawa Frank C Gherardini Clayton Jarrett B Joseph Hinnebusch John T Belisle Jeffery Fairman Catharine M Bosio Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. PLoS Pathogens |
| title | Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. |
| title_full | Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. |
| title_fullStr | Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. |
| title_full_unstemmed | Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. |
| title_short | Effective, broad spectrum control of virulent bacterial infections using cationic DNA liposome complexes combined with bacterial antigens. |
| title_sort | effective broad spectrum control of virulent bacterial infections using cationic dna liposome complexes combined with bacterial antigens |
| url | http://europepmc.org/articles/PMC2877747?pdf=render |
| work_keys_str_mv | AT robinireland effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens AT normaolivareszavaleta effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens AT jonathanmwarawa effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens AT frankcgherardini effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens AT claytonjarrett effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens AT bjosephhinnebusch effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens AT johntbelisle effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens AT jefferyfairman effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens AT catharinembosio effectivebroadspectrumcontrolofvirulentbacterialinfectionsusingcationicdnaliposomecomplexescombinedwithbacterialantigens |